203 related articles for article (PubMed ID: 14627174)
41. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment.
Brüggenjürgen B; Ezzat N; Kardos P; Buhl R
Allergy; 2010 Sep; 65(9):1108-15. PubMed ID: 20121768
[TBL] [Abstract][Full Text] [Related]
42. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
Aballéa S; Cure S; Vogelmeier C; Wirén A
Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
[TBL] [Abstract][Full Text] [Related]
43. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[TBL] [Abstract][Full Text] [Related]
44. Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.
Cukier A; Jacob CM; Rosario Filho NA; Fiterman J; Vianna EO; Hetzel JL; Neis MA; Fiss E; Castro FF; Fernandes AL; Stirbulov R; Pizzichini E;
Respir Med; 2013 Sep; 107(9):1330-8. PubMed ID: 23849625
[TBL] [Abstract][Full Text] [Related]
45. The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.
Chuchalin AG; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
Int J Clin Pract; 2002; 56(1):15-20. PubMed ID: 11833550
[TBL] [Abstract][Full Text] [Related]
46. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain.
Lindgren B; Sears MR; Campbell M; Villasante C; Huang S; Lindh A; Petermann W; Svensson K; Berggren F; Pauwels RA;
Int J Clin Pract; 2005 Jan; 59(1):62-8. PubMed ID: 15707467
[TBL] [Abstract][Full Text] [Related]
49. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
Vogelmeier C; D'Urzo A; Pauwels R; Merino JM; Jaspal M; Boutet S; Naya I; Price D
Eur Respir J; 2005 Nov; 26(5):819-28. PubMed ID: 16264042
[TBL] [Abstract][Full Text] [Related]
50. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
[TBL] [Abstract][Full Text] [Related]
51. Symbicort Turbuhaler: a new concept in asthma management.
Kuna P; Kuprys I
Int J Clin Pract; 2002 Dec; 56(10):797-803. PubMed ID: 12510955
[TBL] [Abstract][Full Text] [Related]
52. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
53. Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.
Ind PW; Haughney J; Price D; Rosen JP; Kennelly J
Respir Med; 2004 May; 98(5):464-75. PubMed ID: 15139576
[TBL] [Abstract][Full Text] [Related]
54. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ; Senn S; Mezzanotte WS
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma.
Ericsson K; Bantje TA; Huber RM; Borg S; Bateman ED
Respir Med; 2006 Apr; 100(4):586-94. PubMed ID: 16274980
[TBL] [Abstract][Full Text] [Related]
56. Overall asthma control: the relationship between current control and future risk.
Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
[TBL] [Abstract][Full Text] [Related]
57. Symbicort: controlling asthma in adults.
Lalloo U
Respir Med; 2002 Feb; 96 Suppl A():S16-22. PubMed ID: 11858561
[TBL] [Abstract][Full Text] [Related]
58. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
[TBL] [Abstract][Full Text] [Related]
59. Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study.
Kardos P
Pneumologie; 2013 Aug; 67(8):463-70. PubMed ID: 23904191
[TBL] [Abstract][Full Text] [Related]
60. Budesonide + formoterol delivered via Spiromax
Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
